My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Merck & Co (NY:MRK)

99.80 +0.35 (+0.35%)

Streaming Delayed Price Updated: 2:12 PM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

98 99 Next >

7 Dividend ETFs to Buy With $2,000 and Hold Forever -- Including the Schwab U.S. Dividend Equity ETF (SCHD) ↗

Today 4:20 EST

It's hard to beat dividend-paying stocks -- in part because they tend to increase their payouts regularly.

Via The Motley Fool

Topics ETFs

Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? ↗

December 14, 2025

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Via The Motley Fool

Topics Intellectual Property

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗

December 12, 2025

They could grow into their valuation over the next few years.

Via The Motley Fool

Topics Intellectual Property

Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles

December 12, 2025

As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

The Green Revolution in Silicon: Semiconductor Manufacturing Embraces Sustainability

December 12, 2025

The semiconductor industry, the foundational bedrock of our digital world and the engine powering the explosive growth of artificial intelligence, is undergoing a profound transformation. Driven by...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Economy

2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore

December 11, 2025

Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing...

Via StockStory

Dividend Stocks for 2026: Where to Invest as the Market Cools ↗

December 10, 2025

Via MarketBeat

2 Pharmaceutical Stocks to Buy at a Discount ↗

December 10, 2025

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

Via The Motley Fool

Topics Intellectual Property

Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution

December 09, 2025

New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index...

Via MarketMinute

Topics ETFs Economy Intellectual Property

Explore the top gainers and losers within the S&P500 index in today's session. ↗

December 09, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.

Via Chartmill

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗

December 09, 2025

The company is finding ways to overcome the headwinds it will encounter in the medium term.

Via The Motley Fool

1 Major Factor Behind the Healthcare Sector's Recent Surge ↗

December 09, 2025

Blockbuster drugs are a major driver of the growth of healthcare stocks.

Via The Motley Fool

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

December 07, 2025

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.

Via The Motley Fool

Topics Economy Stocks

Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗

December 07, 2025

After a long hiatus, why are the bulls so willing to buy in now?

Via The Motley Fool

Topics Intellectual Property

Do These 3 Healthcare Stocks Need a Checkup? ↗

December 05, 2025

These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?

Via The Motley Fool

Topics Intellectual Property

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗

December 05, 2025

The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here.

Via The Motley Fool

Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗

December 05, 2025

The rebound is well underway.

Via The Motley Fool

Topics Death

These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗

December 05, 2025

After tepid performances throughout most of 2025, these stocks are showing some upward momentum.

Via The Motley Fool

Topics Stocks

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗

December 05, 2025

Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year.

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Via The Motley Fool

Topics ETFs Stocks

Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035

December 03, 2025

The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,...

Via MarketMinute

Topics Artificial Intelligence Death Intellectual Property

Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides

December 02, 2025

Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

2 Monster Stocks in the Making to Buy and Hold ↗

December 02, 2025

There's still time to get in on these rising stars.

Via The Motley Fool

1 Value Stock to Target This Week and 2 We Question

December 01, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion

December 01, 2025

As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and...

Via MarketMinute

Topics Bonds Economy Stocks

Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications

December 01, 2025

New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global...

Via MarketMinute

Topics Bonds Credit Cards Economy

These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗

November 30, 2025

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

Via The Motley Fool

Topics Energy Intellectual Property

3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗

November 30, 2025

There are plenty of potential winners outside the world of AI.

Via The Motley Fool

Topics Artificial Intelligence

Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%? ↗

November 29, 2025

The struggling pharmaceutical giant is showing signs of life.

Via The Motley Fool

Dow Industrials Erase November Losses: A Beacon of Optimism Amidst Market Crossroads

November 28, 2025

The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

< Previous 1 2 3 4 5 6 7 8 9

...

98 99 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.